Investor Presentation on Q1 FY27 Financial Results
RESULTS
▲ Positive Development
LOW RISK
📅 Filed on BSE: 29 Jul 2026, 04:59 PM IST · BSE ID: 1d58aaf3-6d7c-4b9e-a360-67bb4ea176e8
View Original BSE Filing (PDF)
💡
In Simple Terms
Balaji Amines shared an investor presentation detailing its Q1 FY27 financial performance, showing higher revenue and profit.
🤖 AI Summary
- Balaji Amines reported Q1 FY27 consolidated Total Revenue of INR Cr 461, a 25.73% increase year-over-year.
- Consolidated Profit After Tax (PAT) for Q1 FY27 stood at INR Cr 78, reflecting a 110.19% YoY growth.
- The company commissioned India's first commercial-scale 100,000 TPA Dimethyl Ether plant during Q1 FY27.
- NMM and Acetonitrile expansion projects are on track for commissioning by the end of the current financial year.
- Expansion at Balaji Speciality Chemicals Limited is progressing as planned, as per the investor presentation.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Consolidated Total Revenue (Q1 FY27)
INR Cr 461
25.73%
Consolidated EBITDA (Q1 FY27)
INR Cr 121
91.51%
Consolidated Profit After Tax (Q1 FY27)
INR Cr 78
110.19%
Consolidated EBITDA Margin (Q1 FY27)
26%
Consolidated PAT Margin (Q1 FY27)
17%
🏢 How This Affects the Company
The commissioning of India's first 100,000 TPA Dimethyl Ether plant diversifies Balaji Amines into new-age chemicals and alternate fuels, supporting import substitution. Continued progress on NMM, Acetonitrile, and Balaji Speciality Chemicals Limited expansion projects indicates future capacity growth and portfolio strengthening.
Consolidated Total Revenue increased by 25.73% to INR Cr 461 and Profit After Tax increased by 110.19% to INR Cr 78 in Q1 FY27, improving profitability. EBITDA Margin expanded to 26% and PAT Margin to 17% in Q1 FY27, compared to Q1 FY26's 17% and 10% respectively.
The commissioning of the Dimethyl Ether plant adds a significant new manufacturing capability and product line. The ongoing NMM and Acetonitrile expansion projects will further increase production capacity upon commissioning by the end of FY27.
The diversification into new-age chemicals with the Dimethyl Ether plant reduces reliance on existing product lines and reinforces commitment to import substitution, potentially mitigating supply chain risks.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders based on this investor presentation.
👤
Who Is Affected
All shareholders are affected by the company's financial performance and strategic project updates, indicating business expansion and improved profitability.
🔍
Management Signal
Management emphasizes strong operational and financial performance, diversification into new-age chemicals, and continued execution of expansion projects.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Q2 FY27 financial results — check for sustained revenue and profit growth.
Updates on NMM and Acetonitrile expansion project commissioning by FY27 end.
Further details on the market reception and revenue contribution from the Dimethyl Ether plant.
LOW RISK
The filing reports strong financial results and progress on expansion projects without highlighting new or elevated risks.
💡 Investor Takeaway
Balaji Amines reported Q1 FY27 consolidated Total Revenue of INR Cr 461, a 25.73% YoY increase, and Profit After Tax of INR Cr 78, up 110.19% YoY. The company commissioned India's first 100,000 TPA Dimethyl Ether plant and has expansion projects on track.
⚖️ Strengths & Concerns
✅ Positives
- Q1 FY27 consolidated Profit After Tax (PAT) increased by 110.19% year-over-year to INR Cr 78.
- Commissioned India's first commercial-scale 100,000 TPA Dimethyl Ether plant, diversifying into new chemical streams.
📅 Company Track Record
Balaji Amines previously reported Q1 FY27 consolidated net profit up 110.81% to ₹ 78 Crore and Q4 FY26 consolidated net profit up 62.50% to ₹ 65 Crore. FY26 profit was Rs 16,552.83 Lakhs, with a recommended Rs 11/- dividend.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What was Balaji Amines' consolidated Total Revenue for Q1 FY27?
Balaji Amines reported a consolidated Total Revenue of INR Cr 461 for Q1 FY27, an increase of 25.73% compared to INR Cr 367 in Q1 FY26.
What was Balaji Amines' consolidated Profit After Tax (PAT) in Q1 FY27?
The consolidated Profit After Tax for Balaji Amines in Q1 FY27 was INR Cr 78, reflecting a 110.19% increase from INR Cr 37 in Q1 FY26.
What significant plant commissioning did Balaji Amines announce in Q1 FY27?
Balaji Amines announced the commissioning of India's first commercial-scale 100,000 TPA Dimethyl Ether plant during Q1 FY27.
What are Balaji Amines' ongoing expansion project timelines for FY27?
Balaji Amines' NMM and Acetonitrile expansion projects are on track for commissioning by the end of FY27, with Balaji Speciality Chemicals Limited's expansion also progressing.
Questions based on this BSE filing only. For information purposes.